1-ETHYLPYRIDINIUM TETRAFLUOROBORATE, 99%, 100g

3-m-Tolyloxetan-3-amine hydrochloride, 95.0%, 1g

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, 95%, 1g

Bis[(2-diphenylphosphino)phenyl] ether, 95.0%, 500g

(S)-5-methyl-5-azaspiro[2.4]heptane-6-carboxylic acid, 95.0%, 100mg

3-Boc-3,9-Diazaspiro[5.5]undecane, 97.0%, 250mg

3-[1-(Dimethylamino)ethyl]phenol, 95.0%, 25g

4-Bromo-2-iodophenol, 95.0%, 100g

Magnesium chloride hexahydrate, min. 99%, pa, ACS, 1 kg, plastic packaging.

Closing caps SILICOSEN®, C-30, Gesch. front, 18-30 mm 10 pcs

6-Methoxyquinoline, 95.0%, 1g

Fmoc-(S)-3-Amino-4-(1-naphthyl)-butyric acid, 97%, 100mg

tert-Butyl 3-(hydroxymethyl)-1-isopropyl-4,5-dihydro-1H-pyrazolo[3,4-c]pyridine-6(7H)-carboxylate, 95+%, 250mg